Welcome message

Dear Participants,


In challenging moments such as the ones that we are all living, the importance of the Healthcare field is being proved and highlighted. Being part of this field, Nuclear Medicine is suffering constraints but could not be totally stopped, and this fact includes its focus on clinical practice, but also all the involved research and education activities.


Considering this, and even in a complex context in which the organization of big presential gatherings and meetings is impossible, it is was decided by the Nuclear Medicine Department of the School of Health of the Polytechnic Institute of Porto that its bigger annual scientific event should continue to take place. As usual, it is aimed to provide community with a beneficial service that is a strategic goal that should be addressed, a reason that justifies such effort in a busy moment for all. However, considering rules and protective measures in force, for the first time, Nuclear Medicine Symposium of ESS will become entirely online. Also, for the first time registration will be free of charge.


And it is with honour and respect that I start to salute you all, and to thank you the confidence in our team demonstrated by your attendance/participation in our IV Symposium of Nuclear Medicine of ESS|P.Porto.



As a global overview, we can promise a Scientific Programme that will be divided in two half-days (afternoon of Friday, 19th February, and morning of Saturday, 20th February), starting in an overview of the impact of the current pandemic on several different realities within the Nuclear Medicine field (education, clinical practice, industry, research,…) as a starting point to look into the promising future of this specialty, with the exploration of the bigger disruptive technological advances of the last years and an overview of modern clinical applications.


We want to take the past, work in the present and project the future!



Welcome! We hope that you could enjoy our event!

Best regards,


Pedro Costa

Coordinator of the Nuclear Medicine Department